QAAGZX
ETF
QAAGZX
·
UNKNOWN
·
136 holdings
Quick Summary
Price History
Concentration Risk
46.63%
Top-heavy
Low risk
High risk
The top 10 holdings account for 46.63%. The biggest positions move the needle, but there's enough spread to cushion a single-stock blowup.
Top Holdings Today
Weighted by position size
LLY
▼ -0.44%
UNH
▲ 0.46%
ISRG
▼ -2.03%
SYK
▼ -0.41%
TMO
▼ -1.75%
ARGX
▼ -0.49%
VRTX
▼ -0.10%
BSX
▼ -0.45%
DHR
▼ -1.93%
ALNY
▼ -1.68%
Weighted avg. of top holdings
▼ -0.72%
Sector Allocation
Healthcare
79.56%
Manufacturing
0.46%
Top 10 Holdings
46.63% of fund
LLY
Eli Lilly & Co
UNH
UnitedHealth Group Inc
ISRG
Intuitive Surgical Inc
SYK
Stryker Corp
TMO
Thermo Fisher Scientific Inc
ARGX
Argenx SE
VRTX
Vertex Pharmaceuticals Inc
BSX
Boston Scientific Corp
DHR
Danaher Corp
ALNY
Alnylam Pharmaceuticals Inc
Other positions
All Holdings (136)
| # | Ticker | Name | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 10.70% | 85,488 | 70.61 M |
| 2 | UNH | UnitedHealth Group Inc | 7.09% | 89,328 | 46.79 M |
| 3 | ISRG | Intuitive Surgical Inc | 4.94% | 65,792 | 32.58 M |
| 4 | SYK | Stryker Corp | 4.45% | 78,853 | 29.35 M |
| 5 | TMO | Thermo Fisher Scientific Inc | 3.96% | 52,560 | 26.15 M |
| 6 | ARGX | Argenx SE | 3.54% | 39,472 | 23.36 M |
| 7 | VRTX | Vertex Pharmaceuticals Inc | 3.26% | 44,425 | 21.54 M |
| 8 | BSX | Boston Scientific Corp | 3.12% | 204,239 | 20.60 M |
| 9 | DHR | Danaher Corp | 3.06% | 98,607 | 20.21 M |
| 10 | ALNY | Alnylam Pharmaceuticals Inc | 2.52% | 61,636 | 16.64 M |
Showing top 10 of 136 holdings
·
Listed: 90.68%
·
9.32% in other positions
Related ETFs
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: N/A
Profitability
ROE: N/A · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: N/A
Safety
D/E: N/A · Current: N/A| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: N/A · EV/EBITDA: N/A
Valuation
P/E: N/A · EV/EBITDA: N/A| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | N/A | Enterprise Value | N/A |
Per Share
EPS: N/A · FCF/Share: N/A
Per Share
EPS: N/A · FCF/Share: N/A| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
مقارنة الأقران
مقابل وسيط قطاع ETF (25157 نظير)
مقارنة بشركات مشابهة في ETF
مقارنة الأقران
مقابل وسيط قطاع ETF (25157 نظير) مقارنة بشركات مشابهة في ETF| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | — | — |
| P/B | — | — |
| ROE % | — | — |
| Net Margin % | — | — |
| Rev Growth 5Y % | — | — |
| D/E | — | — |
{"event":"ticker_viewed","properties":{"ticker":"QAAGZX","listing_kind":"etf","pathname":"/etfs/qaagzx","exchange":"UNKNOWN","country":"US"}}



